Upgrade to SI Premium - Free Trial

FDA accepts PolyPid's D-PLEX100 NDA with priority review

July 29, 2026 8:30 AM
PolyPid Ltd. (NASDAQ: PYPD) announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA